Welcome to Taiwan Medical and Biotech Industry Association.
  Message from Chairman  

Francis Hong

May 15, 2017

Chairman’s message
Taiwan Medical and Biotech Industry Association

I would like to take this opportunity to express my appreciation to all members and directors of the Taiwan Medical and Biotech Industry Association who elected me the 19th chairman of the association. I take this as a great challenge and responsibility for me.

The Taiwan Medical and Biotech Industry Association (TMBIA) has been established for more than 50 years. The current production value of Taiwan’s medical equipment is resulted from the constant and diligent efforts made by the industry. Have gained recognition and respect from the government and people from all walks of life, Taiwan’s medical industry has been made one of the 5+2 strategic industries for national development.

However, in the face of growing protectionism and the wave of anti-globalization, Taiwan’s medical industry, which is mainly based on small and medium enterprises, is unable to single-handedly make inroad into the overseas markets and suvive through their own brands, if without the injection of government resources.

To develop the biotech industry and medical equipment, the primary task for Taiwan is to stipulate the industrial policy for medical development jointly by the industry, the government, the academics, the research institutions, and the medical sector. Afterwards, the medical equipment makers could explore the markets abroad and involve in the international health and medical chains so as to gain business reputation. Additionally, the government should encourage the domestic medical facilities to utilize Taiwan-made medical devices. It is generally believed that under the government’s supports and the efforts made by the manufacturers of the medical devices, a handful of “TSMC” could be developed.

The Taiwan Medical and Biotech Industry Association backs the government in advancing the legislation of the “Medical Equipment Management Bill” and is pleased to see the relaxation of certain regulations concerned. We support the opening up of our doors to seeking foreign talents in order to escalate the level of our research and manufacturing. The association also appeals to the government to grant reasonable freedom of speech to the advertising given by our manufacturers of medical devices. We also urge that certification of international bilateral documents be conducted based on mutual benefits to reduce redundancy of factory examinations as well as clinical and non-clinical trials.

Unlike in the past when the medical and drug sector across the Taiwan Straits enjoyed more cooperation and negotiation, the Taiwan Food and Drug Administration (TFDA) the Ministry of Health and Welfare and the China Food and Drug Administration (CFDA) have stopped the regular negotiating mechanism. As a result of the lack of information exchanges on medical devices supervision and control, and the unawareness of our members towards mainland China’s changes of regulations, a great many resources have been wasted. The members of our association must make efforts to re-establish new relationships. With real ability, could they be able to market their products in the emerging markets of mainland China. The association should take initiative to establish a two-way mechanism to study “How to re-open negotiations” to catch hold of China’s business  opportunities, with the greatest haste in resuming and activating dialog on trade and regulations on medical industry across the Taiwan Straits.

Following the launch of the New Southbound Policy by the government, the responses of the TMBIA members are generally reflected as follows: To cope with the global economic structure and to explore more business opportunities, the government’s intention is good. Nevertheless, it does not totally meet the needs and demands of our member companies and the Southeast Asian nations. I therefore put forth a proposal: the Taiwan Medical and Biotech Industry Association integrates with member factories to call upon the government to provide effectives resources and funds to be used to help TMBIA set up overseas sales offices with the help of our representative offices or diplomatic organizations. We aim at proactively and aggressively seeking business opportunities for our members.

As most of our members are small and medium enterprises, the domestic market is not big enough to maintain the elementary business needs. In the face of competition by major foreign manufacturers, our members encounter even more hardship. I therefore propose that our members enter into an alliance with other industries, putting similar medical products’ rules and regulations, research and development, marketing and production into a suitable integration. Through integrated resources, concentration of resources and avoidance of wastage, our member factories would take a new way of business operation to cope with severe market challenges.

I have served for 24 years in the association, witnessing its growth and expansion. It is my pleasure to see the accomplishments if our members achieved through years of hard work and devotion. TMBIA is a precious public platform. Let’s build a bridge between our members, our government and the world, enabling the best made-in-Taiwan medical products to be sold worldwide and benefit all humanity.

The Taiwan Medical and Biotech Industry Association belongs to all. I will exert my utmost to service my members. I am grateful and eagerly seeking advice from my predecessors and co-workers, believing that collective wisdom works better than one’s.



Francis Hong
Taiwan Medical and Biotech Industry Association